These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 11511522)
1. Membrane-type matrix metalloproteinase-1 and -3 activity in primate smooth muscle cells. Shofuda KI; Hasenstab D; Kenagy RD; Shofuda T; Li ZY; Lieber A; Clowes AW FASEB J; 2001 Sep; 15(11):2010-2. PubMed ID: 11511522 [TBL] [Abstract][Full Text] [Related]
2. Control of smooth muscle cell function by membrane-type matrix metalloproteinases. Shofuda KI; Hasenstab D; Shofuda T; Kenagy RD; Clowes AW Ann N Y Acad Sci; 2001 Dec; 947():337-40. PubMed ID: 11795285 [TBL] [Abstract][Full Text] [Related]
3. Elevated expression of membrane-type 1 and 3 matrix metalloproteinases in rat vascular smooth muscle cells activated by arterial injury. Shofuda K; Nagashima Y; Kawahara K; Yasumitsu H; Miki K; Miyazaki K Lab Invest; 1998 Aug; 78(8):915-23. PubMed ID: 9714179 [TBL] [Abstract][Full Text] [Related]
5. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064 [TBL] [Abstract][Full Text] [Related]
6. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system. Jo Y; Yeon J; Kim HJ; Lee ST Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509 [TBL] [Abstract][Full Text] [Related]
7. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor. Nabeshima K; Inoue T; Shimao Y; Okada Y; Itoh Y; Seiki M; Koono M Cancer Res; 2000 Jul; 60(13):3364-9. PubMed ID: 10910039 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of the inhibitory effect of epigallocatechin-3-gallate on cultured human vascular smooth muscle cell invasion. Cheng XW; Kuzuya M; Nakamura K; Liu Z; Di Q; Hasegawa J; Iwata M; Murohara T; Yokota M; Iguchi A Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1864-70. PubMed ID: 16051878 [TBL] [Abstract][Full Text] [Related]
9. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545 [TBL] [Abstract][Full Text] [Related]
10. In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity. El Fahime E; Torrente Y; Caron NJ; Bresolin MD; Tremblay JP Exp Cell Res; 2000 Aug; 258(2):279-87. PubMed ID: 10896779 [TBL] [Abstract][Full Text] [Related]
11. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Augé N; Maupas-Schwalm F; Elbaz M; Thiers JC; Waysbort A; Itohara S; Krell HW; Salvayre R; Nègre-Salvayre A Circulation; 2004 Aug; 110(5):571-8. PubMed ID: 15277330 [TBL] [Abstract][Full Text] [Related]
12. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism. Monea S; Lehti K; Keski-Oja J; Mignatti P J Cell Physiol; 2002 Aug; 192(2):160-70. PubMed ID: 12115722 [TBL] [Abstract][Full Text] [Related]
13. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells. Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081 [TBL] [Abstract][Full Text] [Related]
14. Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1 -MMP) compartment of proMMP-2 activation in MG-63 cells. Luo XH; Liao EY Horm Metab Res; 2001 Jul; 33(7):383-8. PubMed ID: 11507673 [TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Ohnishi K; Takagi M; Kurokawa Y; Satomi S; Konttinen YT Lab Invest; 1998 Sep; 78(9):1077-87. PubMed ID: 9759652 [TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation. Zhao H; Bernardo MM; Osenkowski P; Sohail A; Pei D; Nagase H; Kashiwagi M; Soloway PD; DeClerck YA; Fridman R J Biol Chem; 2004 Mar; 279(10):8592-601. PubMed ID: 14681236 [TBL] [Abstract][Full Text] [Related]
18. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005 [TBL] [Abstract][Full Text] [Related]
19. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus). Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196 [TBL] [Abstract][Full Text] [Related]
20. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]